Literature DB >> 19122532

Inflammatory markers in depression.

Timothy G Dinan1.   

Abstract

PURPOSE OF REVIEW: To provide a critical update of the literature linking depression and inflammation, together with possible underlying mechanisms and longer term risk of cardiovascular disease. RECENT
FINDINGS: The current literature lends further support to the view that major depression is associated with a proinflammatory response, as indexed by elevation in C-reactive protein and cytokines such as interleukin 6 and tumour necrosis factor-alpha. Antidepressants suppress the inflammatory response, whereas electroconvulsive therapy acutely increases proinflammatory cytokine levels. Most, though not all, studies support a link between depression, inflammation and cardiovascular events.
SUMMARY: Depression is an inflammatory state that may increase the risk of cardiac disease. Whether or not the immune system is an appropriate target for antidepressant development has yet to be established.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122532     DOI: 10.1097/YCO.0b013e328315a561

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  56 in total

1.  Association between depression and vascular disease in systemic lupus erythematosus.

Authors:  Carol M Greco; Tracy Li; Abdus Sattar; Amy H Kao; Natalya Danchenko; Daniel Edmundowicz; Kim Sutton-Tyrrell; Russell P Tracy; Lewis H Kuller; Susan Manzi
Journal:  J Rheumatol       Date:  2011-12-15       Impact factor: 4.666

Review 2.  Physical Exercise and Neuroinflammation in Major Depressive Disorder.

Authors:  Zuleide M Ignácio; Renato S da Silva; Marcos E Plissari; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2019-06-21       Impact factor: 5.590

3.  Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Álvaro Camacho; Britta Larsen; Robyn L McClelland; Cindy Morgan; Michael H Criqui; Mary Cushman; Matthew A Allison
Journal:  J Affect Disord       Date:  2014-04-19       Impact factor: 4.839

Review 4.  Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Authors:  Heath D Schmidt; Richard C Shelton; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

5.  Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages.

Authors:  Katarzyna Nazimek; Michael Kozlowski; Pawel Bryniarski; Spencer Strobel; Agata Bryk; Michal Myszka; Anna Tyszka; Piotr Kuszmiersz; Jaroslaw Nowakowski; Iwona Filipczak-Bryniarska
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-05

6.  Association between depression and inflammation--differences by race and sex: the META-Health study.

Authors:  Alanna Amyre Morris; Liping Zhao; Yusuf Ahmed; Neli Stoyanova; Christine De Staercke; William Craig Hooper; Gary Gibbons; Rebecca Din-Dzietham; Arshed Quyyumi; Viola Vaccarino
Journal:  Psychosom Med       Date:  2011-06-28       Impact factor: 4.312

7.  Gender dysphoria: prejudice from childhood to adulthood, but no impact on inflammation. A cross-sectional controlled study.

Authors:  André Gonzales Real; Anna Martha Vaitses Fontanari; Angelo Brandelli Costa; Bianca Machado Borba Soll; Giovana Bristot; Larissa Fagundes de Oliveira; Ana Maria Kamphorst; Maiko Abel Schneider; Maria Inês Rodrigues Lobato
Journal:  Trends Psychiatry Psychother       Date:  2021-01-22

8.  Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial.

Authors:  Kim E Innes; Terry Kit Selfe; Dharma Singh Khalsa; Sahiti Kandati
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Diabetes, depressive symptoms, and functional disability in African Americans: the Jackson Heart Study.

Authors:  Rita Rastogi Kalyani; Nan Ji; Mercedes Carnethon; Alain G Bertoni; Elizabeth Selvin; Edward W Gregg; Mario Sims; Sherita Hill Golden
Journal:  J Diabetes Complications       Date:  2017-03-09       Impact factor: 2.852

Review 10.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.